Intraductal papillomas are caused by an abnormal overgrowth of the cells that line the breast ducts. These cells multiply faster than normal and form small, finger-like projections that grow inward into the duct, creating a benign tumor. The exact trigger for this overgrowth isn’t fully understood, but hormonal factors, particularly estrogen exposure, play a central role.
How These Growths Form
The inside of each breast duct is lined with a layer of epithelial cells. Normally, these cells grow and replace themselves at a steady rate. In an intraductal papilloma, that process accelerates. As new cells multiply, they’re physically constrained by the outer wall of the duct, so they buckle inward rather than expanding outward. This buckling creates the characteristic finger-like projections that define a papilloma.
The result is a small, wart-like growth attached to the inside of the duct wall. It has its own blood supply, which is why the most common symptom is nipple discharge that’s either clear or blood-stained. Some papillomas are large enough to feel as a small lump near the nipple, while others are too small to detect without imaging.
The Role of Estrogen
Estrogen is one of the strongest known drivers of breast tissue growth, and it plays a significant role in benign breast tumors like papillomas. These growths contain estrogen receptors, meaning they can respond directly to hormonal fluctuations in the body. During periods when estrogen levels are elevated, such as pregnancy or hormone replacement therapy, these tumors may grow faster or be more likely to develop in the first place.
Hormone replacement therapy during menopause has been specifically linked to an increased risk of benign breast tumor growth and recurrence. The same applies to other sources of prolonged estrogen exposure: starting menstruation early, reaching menopause late, or using certain hormonal contraceptives. Each of these extends the total window of time breast tissue is exposed to estrogen, which may raise the likelihood of abnormal cell growth within the ducts.
Other Risk Factors
Beyond hormonal influences, a few additional factors are associated with a higher chance of developing intraductal papillomas:
- Family history: A family history of breast tumors, whether benign or malignant, is a recognized predisposing factor.
- Hormonal contraceptive use: Oral contraceptives and other hormonal birth control methods can influence breast tissue proliferation over time.
- Age: Solitary papillomas most commonly appear in women between the ages of 35 and 55, coinciding with the years of highest hormonal fluctuation leading up to and during menopause.
There’s no strong evidence linking intraductal papillomas to diet, exercise, alcohol, or environmental toxins the way some breast cancers are. The growth appears to be driven primarily by the hormonal environment inside the breast itself.
Solitary vs. Multiple Papillomas
Not all intraductal papillomas behave the same way, and the distinction between the two types matters for understanding risk.
Solitary papillomas grow in the large, central milk ducts close to the nipple. They’re the more common type and are generally considered an aberration rather than a disease process. A single papilloma does not significantly increase the risk of breast cancer, and many specialists don’t recommend routine follow-up surveillance after removal.
Multiple papillomas are a different situation. These develop in the smaller, peripheral ducts farther from the nipple, typically in the terminal portions of the duct system. They tend to appear in clusters across a segment of the breast. Research from the International Seminars in Surgical Oncology found that all cases of multiple papillomas in one series originated in the most peripheral portion of the duct system, and these peripheral papillomas appear to be significantly more susceptible to malignant transformation. Women with multiple papillomas are generally advised to have annual mammography for ongoing monitoring.
Connection to Breast Cancer
Most intraductal papillomas are benign, but the relationship to cancer isn’t zero. In one surgical series published in JAMA Surgery, solitary papillomas were associated with breast carcinoma in about 10% of cases, and an additional 9% of patients had cancer found within the papilloma itself.
The key factor that changes the risk profile is atypia, which means the cells in or around the papilloma look abnormal under a microscope. Women with atypical papillomas face roughly a fourfold increase in the risk of developing invasive breast cancer compared to those without atypia. Atypia was found in about 6% of papilloma cases in that same series. When no atypia is present, the cancer risk remains relatively low.
This is why a tissue sample is almost always taken when a papilloma is found. On ultrasound, these lesions are most commonly categorized as BI-RADS 4a, a classification that indicates low suspicion for cancer but enough concern to warrant a biopsy for confirmation.
How Papillomas Are Treated
The standard treatment for a symptomatic intraductal papilloma is surgical removal, typically through a procedure that removes the affected duct segment. This resolves the nipple discharge and provides a complete tissue sample to rule out any hidden abnormalities that a needle biopsy might miss.
For solitary papillomas without atypia, removal is often the end of the road. No additional treatment or intensive monitoring is typically needed. For multiple papillomas or any papilloma with atypical cells, closer follow-up with regular imaging is the standard approach, given the elevated risk of future changes in the breast tissue.